Latest Breaking News On - Fudan university huashan hospital - Page 6 : comparemela.com
Vaccines said key to reopen intl borders
chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.
Science’
s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.
On 2 January 2020, a group of clinician-researchers at the Jinyintan Hospital here, along with colleagues at other institutions, launched a study of 41 patients suffering from a new, atypical pneumonia. The team assembled clinical data, laboratory results, and chest x-rays; tracked the production of immune system molecules called cytokines; and noted the use of antivirals, antibiotics, and corticosteroids. Thirteen of the patients required intensive care, and six died.
The group’s observations, published online by
The Lancet on 24 January 2020, were the first dispatch from the clinical front lines of the COVID-19 pandemic and gave clinicians around the world a detailed picture of what to brace for as the virus, then called 2019-nCoV, began to race across the globe. The paper also contained a clear warning: “We are concerned that 2019-nCoV could have acquired the ability for
Medical workers take care of a COVID-19 patient at Union Hospital in Wuhan, China, in April 2020.
PHOTO: XINHUA/SHEN BOHAN/GETTY IMAGES
On 2 January 2020, a group of clinician-researchers at the Jinyintan Hospital here, along with colleagues at other institutions, launched a study of 41 patients suffering from a new, atypical pneumonia. The team assembled clinical data, laboratory results, and chest x-rays; tracked the production of immune system molecules called cytokines; and noted the use of antivirals, antibiotics, and corticosteroids. Thirteen of the patients required intensive care, and six died.
The group s observations, published online by
The Lancet on 24 January 2020, were the first dispatch from the clinical front lines of the COVID-19 pandemic and gave clinicians around the world a detailed picture of what to brace for as the virus, then called 2019-nCoV, began to race across the globe. The paper also contained a clear warning: “We are concerned that 2019-nCoV coul
Beijing Mandates Millions Must Get China-Made COVID-19 Vaccine as Testing Continues
The Chinese regime recently mandated that 50 million doses of COVID-19 vaccines must be administered to people designated as high risk by Feb. 15, 2021 although drug companies have yet to complete testing and the vaccines have yet to be approved by regulators.
Meanwhile, Fosun Pharmaceutical announced that it had ordered 100 million doses of the COVID-19 vaccine developed by German drug company BioNTech, which will arrive in China in 2021. BioNTech has partnered with Pfizer to supply vaccines for the U.S. and EU markets, which were approved by their respective regulators, but the vaccine developed for the China market is still in Phase II trial.
vimarsana © 2020. All Rights Reserved.